These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

205 related items for PubMed ID: 11865410

  • 1. Temporal sequence and functional implications of V beta-specific T cell receptor down-regulation and costimulatory molecule expression following in vitro stimulation with the staphylococcal superantigen Toxic shock syndrome toxin-1.
    Kum WW, Hung RW, Cameron SB, Chow AW.
    J Infect Dis; 2002 Feb 15; 185(4):555-60. PubMed ID: 11865410
    [Abstract] [Full Text] [Related]

  • 2. Regulation of superantigen-induced T cell activation in the absence and the presence of MHC class II.
    Lando PA, Olsson C, Kalland T, Newton D, Kotb M, Dohlsten M.
    J Immunol; 1996 Oct 01; 157(7):2857-63. PubMed ID: 8816390
    [Abstract] [Full Text] [Related]

  • 3. Interferon-beta up-regulates the expression of co-stimulatory molecules CD80, CD86 and CD40 on monocytes: significance for treatment of multiple sclerosis.
    Marckmann S, Wiesemann E, Hilse R, Trebst C, Stangel M, Windhagen A.
    Clin Exp Immunol; 2004 Dec 01; 138(3):499-506. PubMed ID: 15544628
    [Abstract] [Full Text] [Related]

  • 4. Exogenous and endogenous antigens are differentially presented by mast cells to CD4+ T lymphocytes.
    Frandji P, Tkaczyk C, Oskeritzian C, David B, Desaymard C, Mécheri S.
    Eur J Immunol; 1996 Oct 01; 26(10):2517-28. PubMed ID: 8898968
    [Abstract] [Full Text] [Related]

  • 5. Vbeta-restricted T cell adherence to endothelial cells: a mechanism for superantigen-dependent vascular injury.
    Brogan PA, Shah V, Klein N, Dillon MJ.
    Arthritis Rheum; 2004 Feb 01; 50(2):589-97. PubMed ID: 14872503
    [Abstract] [Full Text] [Related]

  • 6. Expression of costimulatory molecules (CD80, CD86, CD28, CD152), accessory molecules (TCR alphabeta, TCR gammadelta) and T cell lineage molecules (CD4+, CD8+) in PBMC of leprosy patients using Mycobacterium leprae antigen (MLCWA) with murabutide and T cell peptide of Trat protein.
    Sridevi K, Neena K, Chitralekha KT, Arif AK, Tomar D, Rao DN.
    Int Immunopharmacol; 2004 Jan 01; 4(1):1-14. PubMed ID: 14975355
    [Abstract] [Full Text] [Related]

  • 7. Temporal sequence and kinetics of proinflammatory and anti-inflammatory cytokine secretion induced by toxic shock syndrome toxin 1 in human peripheral blood mononuclear cells.
    Kum WW, Cameron SB, Hung RW, Kalyan S, Chow AW.
    Infect Immun; 2001 Dec 01; 69(12):7544-9. PubMed ID: 11705931
    [Abstract] [Full Text] [Related]

  • 8. Synergistic effect between CD40 and class II signals overcome the requirement for class II dimerization in superantigen-induced cytokine gene expression.
    Mehindate K, al-Daccak R, Damdoumi F, Mourad W.
    Eur J Immunol; 1996 Sep 01; 26(9):2075-80. PubMed ID: 8814249
    [Abstract] [Full Text] [Related]

  • 9. Evaluation of CD86/CD28 and CD40/CD154 pathways in regulating monocyte-derived CD80 expression during their interaction with allogeneic endothelium.
    Wang P, Liu Z, Wu C, Zhu B, Wang Y, Xu H.
    Transplant Proc; 2008 Oct 01; 40(8):2729-33. PubMed ID: 18929847
    [Abstract] [Full Text] [Related]

  • 10. Essential role for both CD80 and CD86 costimulation, but not CD40 interactions, in allergen-induced Th2 cytokine production from asthmatic bronchial tissue: role for alphabeta, but not gammadelta, T cells.
    Jaffar ZH, Stanciu L, Pandit A, Lordan J, Holgate ST, Roberts K.
    J Immunol; 1999 Dec 01; 163(11):6283-91. PubMed ID: 10570322
    [Abstract] [Full Text] [Related]

  • 11. Toxic shock syndrome toxin-1-induced death is prevented by CTLA4Ig.
    Saha B, Jaklic B, Harlan DM, Gray GS, June CH, Abe R.
    J Immunol; 1996 Nov 01; 157(9):3869-75. PubMed ID: 8892617
    [Abstract] [Full Text] [Related]

  • 12. Dissection of the function of HLA class II and costimulation in B cell-mediated and toxic shock syndrome toxin-1-induced T cell proliferation.
    Dennig D, O'Reilly RJ.
    J Immunol; 1993 Jun 15; 150(12):5231-40. PubMed ID: 7685791
    [Abstract] [Full Text] [Related]

  • 13. Human peripheral gammadelta T cells potentiate the early proinflammatory cytokine response to staphylococcal toxic shock syndrome toxin-1.
    Kalyan S, Chow AW.
    J Infect Dis; 2004 May 15; 189(10):1892-6. PubMed ID: 15122526
    [Abstract] [Full Text] [Related]

  • 14. Acquired resistance to superantigen-induced T cell shock. V beta selective T cell unresponsiveness unfolds directly from a transient state of hyperreactivity.
    Miethke T, Wahl C, Heeg K, Wagner H.
    J Immunol; 1993 May 01; 150(9):3776-84. PubMed ID: 8473732
    [Abstract] [Full Text] [Related]

  • 15. The capacity of the natural ligands for CD28 to drive IL-4 expression in naïve and antigen-primed CD4+ and CD8+ T cells.
    Bian Y, Hiraoka S, Tomura M, Zhou XY, Yashiro-Ohtani Y, Mori Y, Shimizu J, Ono S, Dunussi-Joannopoulos K, Wolf S, Fujiwara H.
    Int Immunol; 2005 Jan 01; 17(1):73-83. PubMed ID: 15569772
    [Abstract] [Full Text] [Related]

  • 16. TNF-alpha, not CD154 (CD40L), plays a major role in SEB-dependent, CD4(+) T cell-induced endothelial cell activation in vitro.
    Baum D, Yaron R, Yellin MJ.
    Cell Immunol; 1998 Nov 25; 190(1):12-22. PubMed ID: 9826442
    [Abstract] [Full Text] [Related]

  • 17. Molecular cloning and comparative analysis of the rhesus macaque costimulatory molecules CD80 (B7-1) and CD86 (B7-2).
    Zhang D, Johnson RP.
    Cell Immunol; 1997 Apr 10; 177(1):9-17. PubMed ID: 9140091
    [Abstract] [Full Text] [Related]

  • 18. Differential response of CD4+ V7+ and CD4+ V7- T cells to T cell receptor-dependent signals: CD4+ V7+ T cells are co-stimulation independent and anti-V7 antibody blocks the induction of anergy by bacterial superantigen.
    Soares LR, Rivas A, Ruegg C, Engleman EG.
    Eur J Immunol; 1997 Jun 10; 27(6):1413-21. PubMed ID: 9209493
    [Abstract] [Full Text] [Related]

  • 19. A novel HLA class II-independent TCR-mediated T cell activation mechanism is distinguished by the V beta specificity of the proliferating oligoclones and their capacity to generate interleukin-2.
    Dennig D, Yan Y, Ferguson K, O'Reilly RJ.
    Cell Immunol; 1996 Aug 01; 171(2):200-10. PubMed ID: 8806788
    [Abstract] [Full Text] [Related]

  • 20. Defining a novel domain of staphylococcal toxic shock syndrome toxin-1 critical for major histocompatibility complex class II binding, superantigenic activity, and lethality.
    Kum WW, Laupland KB, Chow AW.
    Can J Microbiol; 2000 Feb 01; 46(2):171-9. PubMed ID: 10721486
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.